UCSF Limited Submission Opportunities
(Applications through UCSF Limited Submission Program)
- Internal deadline: Jan 5, 2026
V Foundation Breaking Barriers in Cancer Research Grant
Purpose: to support exceptional, creative cancer researchers who have navigated unique challenges to establish their careers. Two grant mechanisms are available: Translational Grant and Scholar Grant. - Deadline: Feb 17, 2026 (submit nominations ASAP)
NIH NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers
Purpose: to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track or equivalent faculty positions.
Intramural Funding Opportunities
For questions about intramural awards, please contact Meredith Donnelly.
- Extended Deadline: Jan 9, 2026
Computational Cancer Research RFA
The Center for Cancer Data Science, a partnership between The Helen Diller Family Comprehensive Cancer Center and the Bakar Computational Health Sciences Institute, is requesting applications for projects in computational cancer research that harness data available in Information Commons/Cancer Commons. - Deadline: Feb 16, 2026
Neurologic Oncology Program RFA
Seeking applications from HDFCCC Neuroloic Oncology Program members for pilot research projects. - Deadline: March 1, 2026
Cancer Control Program RFA
Seeking applications from HDFCCC Cancer Control Program members (or postdocs of Program members) for pilot research projects.
Foundations/Other Sources
- LOI Deadline: Jan 6, 2026
PCORI Award: Partnering Research and Community Organizations for Comparative Clinical Effectiveness Research Across the Cancer Care Continuum
Seeking to fund high-impact, patient-centered comparative clinical effectiveness research (CER) projects led by researcher and community partnerships to focus on advancing care and outcomes across different phases of the cancer care continuum. - Deadline: Jan 9, 2026
NCCN Lung Cancer Screening Quality Improvement Initiative
National Comprehensive Cancer Network (NCCN) in collaboration with Merck Sharp & Dohme Corporation are offering a new funding opportunity in the area of lung cancer screening. Investigators are invited to develop and submit proposals outlining quality improvement and implementation science projects focused on improving the uptake of, and adherence to, lung cancer screening in people at high risk. - Deadline: Jan 9, 2026
Cancer Research Institute IGNITE Award
The Cancer Research Institute (CRI) has issued a request for applications for its IGNITE Award (Inspiring Growth and Nurturing Independence Through Excellence) program. This program supports the transition of outstanding postdoctoral researchers into independent tenure-track cancer investigators. - Extended Deadline: Jan 13, 2026
NCCN Decision Making, Quality of Life, and Outcome Improvement Initiatives in Chronic Myeloid Leukemia (CML)
NCCN, in collaboration with Novartis, is pleased to continue to invite investigators at NCCN Member Institutions to submit proposals for innovative Chronic Myeloid Leukemia (CML) initiatives focused on improving decision making, quality of life, and clinical outcomes. - Deadline: Jan 15, 2026
AACR/Torrey Coast Foundation Transpacific Gastric and Esophageal Cancer Research Partnership Grant
This award will support a multi-institutional team with Principal Investigators from at least one institution in the United States and one in Asia. The focus is on collaborative research in gastric or esophageal cancer, specifically in areas such as resistance, metastasis, innovative treatment strategies (including identifying and characterizing novel targets), and cellular and immunotherapies. Proposals must include plans indicating how the work will be translated into the clinic, including an estimated timeline. - Deadline: Jan 23, 2026
Mount Zion Health Fund RFP
This RFP is a special call for proposals for initiatives that advance health equity, patient well-being, and academic-community collaboration in alignment with MZHF’s restricted fund purposes. Mount Zion Health Fund reflects the Jewish values and legacy of Mount Zion Hospital by supporting programs and research that improve the physical, emotional and spiritual health of vulnerable populations in San Francisco. - Deadline: Jan 30, 2026
California Initiative to Advance Precision Medicine (CIAPM) Grants
Supports representative precision medicine research aimed at reducing health disparities and increasing participation from historically underrepresented groups in biomedical research. Funding will support research that advances precision medicine approaches reflective of California’s diverse communities. - LOI Deadline: Feb 2, 2026
Children's Tumor Foundation Drug Discovery Initiative
This program aims to stimulate neurofibromatosis (NF) drug discovery by funding researchers proposing to investigate novel or repurposing therapies for NF or to validate new NF targets. Proposals are expected to be short and concentrated on obtaining key preliminary data needed to quickly advance to the next step of drug discovery. - LOI Deadline: Feb 3, 2026
Children's Tumor Foundation Clinical Research Award
The Clinical Research Award (CRA) program aims to advance the development of effective clinical treatments, interventions, and management of patients living with neurofibromatosis (NF).
NIH Announcements
If you are a Cancer Center member who is interested in applying and receiving grant writing support, please contact Erin Bank.
- N/A
To view NCI funding opportunities, search here
In accordance with Federal and State law and University policy, the University of California does not discriminate on the basis of age, gender, race, ethnicity, national origin, religion, sexual orientation, gender identity, health, or disability. For detailed information, please visit the Office for the Prevention of Harassment and Discrimination.